Discovery and Brady Obligations in Kickback Trials

Discovery and Brady Obligations in Kickback Trials at a Glance

In kickback trials under the Anti-Kickback Statute, discovery and Brady obligations are central to ensuring fair trials and full disclosure of exculpatory evidence. Courts often scrutinize the scope of discovery, particularly around agent notes and witness statements that may reveal the nature of payment arrangements. The Brady Rule mandates that prosecutors disclose any evidence that is material to the guilt or punishment of the defendant, including evidence that may exonerate or mitigate liability. In the context of anti-kickback litigation, these obligations can significantly affect the outcome of a case, particularly when evidence of a legitimate business arrangement or lack of criminal intent is at stake.

The Legal Framework

The Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), proscribes the offer, payment, solicitation, or receipt of remuneration to induce or reward referrals of items or services payable by a federal health care program. This statute is central to anti-kickback litigation, and its enforcement depends heavily on the evidence uncovered during discovery. Courts may require extensive discovery to determine whether the defendant acted knowingly and willfully, as required for a conviction under the statute.

Discovery disputes in such trials often revolve around the nature of the payment arrangements and the intent of the parties involved. Witness statements and agent notes are frequently at the heart of these disputes, as they may reveal whether the payments were made with the intent to induce referrals or whether they were part of a legitimate business arrangement. Under the Brady Rule, any evidence that could show a lack of criminal intent or that could otherwise affect the outcome of the trial must be disclosed by the prosecution.

The Federal Overlay

The federal Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), makes it a felony to knowingly and willfully offer, pay, solicit, or receive remuneration to induce or reward referrals of items or services payable by a federal health care program. The Stark Law, 42 U.S.C. § 1395nn, separately prohibits physician self-referrals for designated health services payable by Medicare or Medicaid, on strict-liability terms. Both regimes carry safe harbors and exceptions published at 42 C.F.R. § 1001.952. State referral and fee-splitting statutes operate alongside these federal prohibitions and can apply even where no federal program payment is involved.

Reading the Research Desk

For further reading, see practice areas, the Anti-Kickback Statute explained, safe harbors under the Anti-Kickback Statute, AKS and Stark Law overlap, recent decisions, and FAQ.